Aclipse Therapeutics' Unattributed Round

Aclipse Therapeutics raised a round of funding on February 15, 2018.

Aclipse Therapeutics is a private specialty pharmaceutical company focused on developing and differentiated drugs to address orphan diseases with high unmet medical needs.…

Articles about Aclipse Therapeutics' Unattributed Round: